First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure-Reference-Cited by-同舟云学术

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

Published:2022-08 Issue: Volume:204 Page:105361
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Muller Clotilde^ORCID,Tilloy Valentin,Frobert Emilie,Feghoul Linda,Garrigue Isabelle,Lepiller Quentin,Mirand Audrey,Sidorov Egor,Hantz Sébastien,Alain Sophie^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference29 articles.

1. Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice;Alain;J. Antimicrob. Chemother.,2020

2. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: benefits and limits of 3D analysis;Andouard;Antivir. Res.,2016

3. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artiﬁcial chromosome in Escherichia coli: a new approach for construction of HCMV mutants;Borst;J. Virol.,1999

4. The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89;Borst;J. Virol.,2013

5. Original article Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity;Champier;Antivir. Ther.,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of resistant and refractory cytomegalovirus infections after transplantation;Expert Review of Anti-infective Therapy;2024-09-05

2. Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis;The Journal of Infectious Diseases;2024-06-10

3. Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review;Tropical Medicine and Infectious Disease;2024-02-15

4. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir;Infectious Disease Reports;2024-01-18

5. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20